Semax KIT (10 VIALS)

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH) that has been investigated for its effects on neuroprotection, cognitive function, and cellular adaptation to stress.

Research has examined its influence on neurotrophic signaling, including brain-derived neurotrophic factor (BDNF), as well as pathways involved in oxidative stress, inflammation, neurotransmitter regulation, and neuronal survival.

Preclinical studies have explored Semax in models of cerebral ischemia, cognitive impairment, and neurological injury, with findings suggesting potential effects on neuroplasticity and cellular resilience.

Research has also investigated interactions between Semax and the nervous, immune, and neuroendocrine systems. Rather than acting as conventional hormone replacement, Semax is studied as a regulatory peptide that may influence multiple signaling pathways within the central nervous system.

Much of the literature originates from Russian and Eastern European research programs, while independent evidence remains comparatively limited. Semax therefore continues to be investigated as an experimental compound in neuroscience, neuroprotection, stress-response, and cognitive research.

Notable Research:
Ponomarenko GN, et al. (2001) — “Semax: A New Neuroprotective Peptide.” Neuroscience and Behavioral Physiology. 31(3):265-270.